Can HbA1c Levels Be Used as a Prognostic Tool for Patients Undergoing Coronary Interventions?

JACC Cardiovasc Interv. 2021 May 24;14(10):1159. doi: 10.1016/j.jcin.2021.03.012.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Glycated Hemoglobin
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Prognosis
  • Treatment Outcome

Substances

  • Glycated Hemoglobin A